We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

U.S. High Court To Hear Fosamax Preemption Case Jan. 7; Solicitor General Included

(December 3, 2018, 12:52 PM EST) -- WASHINGTON, D.C. — Arguments about whether the Food and Drug Administration rejected a stronger warning about leg fractures on the label of the osteoporosis drug Fosamax will be heard by the...
To view the full article, register now.